USE OF TRIFLUOPERAZINE IN CHRONIC NEGRO SCHIZOPHRENICS
Abstract
It is realized that only tentative conclusions can be drawn from such a small series. We can say, however, that our results thus far are encouraging and in some cases quite dramatic. Prompt initial improvement in such difficult cases and in such small dosage makes further study seem imperative. Indeed, we have now undertaken investigation of the effects of trifluoperazine on a much larger group in our patients over a more extended period. The absence so far of any serious side symptoms has also been impressive.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
